These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A visit to India: drug prices, research, & global access.
    Author: Scondras D.
    Journal: AIDS Treat News; 1999 Jan 22; (No 311):6-8. PubMed ID: 11366155.
    Abstract:
    Drugs manufactured in India are 1,000 to 4,000 percent cheaper than the same product in U.S. pharmacies. Because of the possible effect on profits, drug companies are working hard to stop India and other nations that make inexpensive copies of lifesaving medicines. Most drugs are inexpensive to manufacture, but U.S. drug companies charge what the market will bear as they strive to recover research and development costs and make a profit for shareholders. It is suggested that the public good would be better served if government took a more active role in fighting HIV.
    [Abstract] [Full Text] [Related] [New Search]